Fall Dinghy (Standard) at StFYCOctober 25 - 26
Result
PosBoatNameTotalRace 1Race 2Race 3Race 4
1199793Rodion Mazin91(1)3(4)2(6)3 (9)
2199537Stephen Bourdow12T9(9)1(10)1(11)1 (12)
3167136Emilio Castelli12T3(3)4(7)3(10)2 (12)
4188888Kurt Wessels214(4)2(6)4(10)11 (21)
5198739David Lapier222(2)6(8)5(13)9 (22)
6195943David Anthes24T6(6)7(13)7(20)4 (24)
7173666Mike Bishop24T8(8)5(13)6(19)5 (24)
8197160Parker Dittmore275(5)8(13)8(21)6 (27)
9206086Douglas Seeman327(7)9(16)9(25)7 (32)
10167444William Sutton IV48DNS(15)13(28)10(38)8 (46)
11175130Peter Strumph52T10(10)11(21)DNS(36)14 (50)
12173687Nicholas Roche52TDNS(15)12(27)11(38)12 (50)
13192874Joao Botto54DNS(15)10(25)DNS(40)10 (50)
14191555Jorge Iriso64DNS(15)DNS(30)DNS(45)13 (58)
export csv


Regatta Message Board

Reply | Post New Message | All Messages | this message is spam
Author: Ved (yourm...@gmail.com) contact the author
Subject: ArreltY
Info: (1291 views) Posted: Tuesday 2-21-23 08:19:28 AM
For the patient who has never inhaled and doesnt want to start now, Opticanns neatly packaged and highly processed products offer few clues that there are plant ingredients inside. You wont find flower, concentrates, high-THC, or accessories here. This provider is best for patients who want the benefits of medical cannabis, but not the cannabis itself. In June 2018, the Cannabis Act made cannabis use completely legal throughout the country. As such, the cannabis industry has flourished. Heres a list of Canadian marijuana stocks you might add to your portfolio. The industry has been growing rapidly in anticipation of higher demand after the legalization of cannabis for non-medical purposes sometime in 2018. Many of the existing companies currently producing cannabis for medical purposes intend to produce and sell cannabis for non-medical purposes as well, after legalization. New cannabis businesses are continuing to be licensed and some existing ones have merged. https://jaidenizoc198643.dsiblogger.com/38571453/street-price-of-... The Regulations Amending Certain Regulations Concerning Cannabis Research and Testing and Cannabis Beverages and the Order Amending Schedule 3 to the Cannabis Act came into force on December 2, 2022, and will be published in the Canada Gazette, Part II on December 21, 2022. Physician authorization forms for medical cannabis should allow daily dose to be expressed as milligrams per day of the desired cannabinoid, together with the desired ratio of cannabinoids expressed in milligrams per milliliter (e.g., 1:20 THC:CBD). To ensure patients have an uninterrupted supply of their medical cannabis, a range of concentrations within the ratio could be provided (e.g., 0.51:1822 THC:CBD). Furthermore, authorization forms should be revised to allow for more than 1 product for the same patient.

Reply | Post New Message | All Messages | this message is spam
  • ArreltY (1292 views) [x] (current)
    Ved ~ Tuesday 2-21-23 08:19:28 AM